1. Home
  2. DRH vs OGN Comparison

DRH vs OGN Comparison

Compare DRH & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Diamondrock Hospitality Company

DRH

Diamondrock Hospitality Company

N/A

Current Price

$9.83

Market Cap

1.9B

Sector

Real Estate

ML Signal

N/A

Logo Organon & Co.

OGN

Organon & Co.

N/A

Current Price

$7.94

Market Cap

1.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DRH
OGN
Founded
2004
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.8B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
DRH
OGN
Price
$9.83
$7.94
Analyst Decision
Buy
Hold
Analyst Count
9
4
Target Price
$9.81
$11.63
AVG Volume (30 Days)
2.7M
4.6M
Earning Date
01-01-0001
05-14-2026
Dividend Yield
3.22%
1.01%
EPS Growth
N/A
N/A
EPS
N/A
1.50
Revenue
N/A
$6,403,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$2.30
$1.65
P/E Ratio
$38.41
$5.32
Revenue Growth
N/A
2.24
52 Week Low
$6.19
$6.18
52 Week High
$10.24
$16.12

Technical Indicators

Market Signals
Indicator
DRH
OGN
Relative Strength Index (RSI) 60.48 51.83
Support Level $8.99 $6.48
Resistance Level $10.24 $10.40
Average True Range (ATR) 0.29 0.38
MACD 0.01 0.00
Stochastic Oscillator 63.89 80.30

Price Performance

Historical Comparison
DRH
OGN

About DRH Diamondrock Hospitality Company

Diamondrock Hospitality Company is a real estate investment trust that owns lodging properties. Its business is to acquire, own, manage, and renovate full-service hotel properties in the United States. It operates in cities such as Chicago, Boston, New York, Denver, and others. Within DiamondRock's holdings, the majority of the hotel brands include Marriott, Starwood, and Hilton. The revenue is divided between room, food and beverage, and others. The room segment contributes the majority of the revenue. The firm's customers include leisure transients, business transients, and group customers.

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Share on Social Networks: